136 related articles for article (PubMed ID: 10027012)
1. The PreS2 activators of the hepatitis B virus: activators of tumour promoter pathways.
Hildt E; Hofschneider PH
Recent Results Cancer Res; 1998; 154():315-29. PubMed ID: 10027012
[TBL] [Abstract][Full Text] [Related]
2. The PreS2 activator MHBs(t) of hepatitis B virus activates c-raf-1/Erk2 signaling in transgenic mice.
Hildt E; Munz B; Saher G; Reifenberg K; Hofschneider PH
EMBO J; 2002 Feb; 21(4):525-35. PubMed ID: 11847101
[TBL] [Abstract][Full Text] [Related]
3. The hepatitis B virus large surface protein (LHBs) is a transcriptional activator.
Hildt E; Saher G; Bruss V; Hofschneider PH
Virology; 1996 Nov; 225(1):235-9. PubMed ID: 8918553
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus protein preS2 potentially promotes HCC development via its transcriptional activation of hTERT.
Luan F; Liu H; Gao L; Liu J; Sun Z; Ju Y; Hou N; Guo C; Liang X; Zhang L; Sun W; Ma C
Gut; 2009 Nov; 58(11):1528-37. PubMed ID: 19651630
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus-induced oncogenesis.
Lupberger J; Hildt E
World J Gastroenterol; 2007 Jan; 13(1):74-81. PubMed ID: 17206756
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus transcriptional activators: mechanisms and possible role in oncogenesis.
Henkler F F; Koshy R
J Viral Hepat; 1996 May; 3(3):109-21. PubMed ID: 8871869
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus PreS2-mutant large surface antigen activates store-operated calcium entry and promotes chromosome instability.
Yen TT; Yang A; Chiu WT; Li TN; Wang LH; Wu YH; Wang HC; Chen L; Wang WC; Huang W; Chang CW; Chang MD; Shen MR; Su IJ; Wang LH
Oncotarget; 2016 Apr; 7(17):23346-60. PubMed ID: 26992221
[TBL] [Abstract][Full Text] [Related]
8. HBV preS2 transactivates FOXP3 expression in malignant hepatocytes.
Zhang X; Gao L; Liang X; Guo M; Wang R; Pan Y; Liu P; Zhang F; Guo C; Zhu F; Qu C; Ma C
Liver Int; 2015 Mar; 35(3):1087-94. PubMed ID: 25047684
[TBL] [Abstract][Full Text] [Related]
9. The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator.
Kekulé AS; Lauer U; Meyer M; Caselmann WH; Hofschneider PH; Koshy R
Nature; 1990 Feb; 343(6257):457-61. PubMed ID: 2153938
[TBL] [Abstract][Full Text] [Related]
10. The hepatitis B virus preS2/St transactivator utilizes AP-1 and other transcription factors for transactivation.
Lauer U; Weiss L; Lipp M; Hofschneider PH; Kekulé AS
Hepatology; 1994 Jan; 19(1):23-31. PubMed ID: 8276360
[TBL] [Abstract][Full Text] [Related]
11. Integrity of c-Raf-1/MEK signal transduction cascade is essential for hepatitis B virus gene expression.
Stöckl L; Berting A; Malkowski B; Foerste R; Hofschneider PH; Hildt E
Oncogene; 2003 May; 22(17):2604-10. PubMed ID: 12730674
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus-expressed preS2 antibody inhibits hepatitis B virus infection and hepatic carcinogenesis.
Zhang Q; Li ZQ; Liu H; Yang JH
World J Gastroenterol; 2012 Jan; 18(4):349-55. PubMed ID: 22294841
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of Hepatitis B virus sub-genotypes and incidence of preS1/preS2 region mutations in HBV-infected Egyptian patients from Mansoura.
El-Mowafy M; Elgaml A; El-Mesery M; Elegezy M
J Med Virol; 2017 Sep; 89(9):1559-1566. PubMed ID: 28390175
[TBL] [Abstract][Full Text] [Related]
14. Ground-glass hepatocytes co-expressing hepatitis B virus X protein and surface antigens exhibit enhanced oncogenic effects and tumorigenesis.
Wu HC; Tsai HW; Teng CF; Hsieh WC; Lin YJ; Wang LH; Yuan Q; Su IJ
Hum Pathol; 2014 Jun; 45(6):1294-301. PubMed ID: 24767856
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus pre-S2 mutant large surface protein inhibits DNA double-strand break repair and leads to genome instability in hepatocarcinogenesis.
Hsieh YH; Chang YY; Su IJ; Yen CJ; Liu YR; Liu RJ; Hsieh WC; Tsai HW; Wang LH; Huang W
J Pathol; 2015 Jul; 236(3):337-47. PubMed ID: 25775999
[TBL] [Abstract][Full Text] [Related]
16. HBV preS2 promotes the expression of TAZ via miRNA-338-3p to enhance the tumorigenesis of hepatocellular carcinoma.
Liu P; Zhang H; Liang X; Ma H; Luan F; Wang B; Bai F; Gao L; Ma C
Oncotarget; 2015 Oct; 6(30):29048-59. PubMed ID: 26315112
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibitor suberoylanilide hydroxamic acid suppresses the pro-oncogenic effects induced by hepatitis B virus pre-S2 mutant oncoprotein and represents a potential chemopreventive agent in high-risk chronic HBV patients.
Hsieh YH; Su IJ; Yen CJ; Tsai TF; Tsai HW; Tsai HN; Huang YJ; Chen YY; Ai YL; Kao LY; Hsieh WC; Wu HC; Huang W
Carcinogenesis; 2013 Feb; 34(2):475-85. PubMed ID: 23172669
[TBL] [Abstract][Full Text] [Related]
18. Non-sequencing molecular approaches to identify preS2-defective hepatitis B virus variants proved to be associated with severe liver diseases.
Raimondo G; Costantino L; Caccamo G; Pollicino T; Squadrito G; Cacciola I; Brancatelli S
J Hepatol; 2004 Mar; 40(3):515-9. PubMed ID: 15123368
[TBL] [Abstract][Full Text] [Related]
19. Chemical-induced degradation of PreS2 mutant surface antigen via the induction of microautophagy.
Yang JY; Wu YH; Pan MY; Chiou YT; Lee RK; Li TN; Wang LH
Antiviral Res; 2022 Nov; 207():105417. PubMed ID: 36122619
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B.
Murata M; Matsuzaki K; Yoshida K; Sekimoto G; Tahashi Y; Mori S; Uemura Y; Sakaida N; Fujisawa J; Seki T; Kobayashi K; Yokote K; Koike K; Okazaki K
Hepatology; 2009 Apr; 49(4):1203-17. PubMed ID: 19263472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
